Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Erlichman

Showing results (61-70 of 95) with videos related to

Pageof 10
Sort By:
Cancer Research|December 1, 1991
Phase I pharmacokinetic and pharmacodynamic study of a new anthrapyrazole, CI-937 (DUP937)C Erlichman, M Moore, I G Kerr, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1994
Variability in the pharmacokinetics of cyclophosphamide, methotrexate and 5-fluorouracil in women receiving adjuvant treatment for breast cancerM J Moore, C Erlichman, J J Thiessen, et al.
Cancer Chemotherapy and Pharmacology|April 9, 2013
Open-label, dose-escalation, safety, pharmacokinetic, and pharmacodynamic study of intravenously administered CNF1010 (17-(allylamino)-17-demethoxygeldanamycin [17-AAG]) in patients with solid tumorsM W Saif, C Erlichman, T Dragovich, et al.
Arzneimittel-Forschung|June 1, 1988
Disposition of cyclophosphamide on two consecutive cycles of treatment in patients with ovarian carcinomaC Erlichman, S J Soldin, R W Hardy, et al.
Cancer|November 7, 1998
Molecular markers in male breast carcinomaD Rayson, C Erlichman, V J Suman, et al.
Cancer Treatment Reports|March 1, 1982
Combined radical radiation therapy and chemotherapy for primary squamous cell carcinoma of the anal canalB J Cummings, W D Rider, A R Harwood, et al.
American Journal of Clinical Oncology|February 1, 1996
A phase II trial of 5-fluorouracil and 1-leucovorin in patients with metastatic colorectal cancerC Erlichman, S Fine, I Kerr, et al.
Gene Therapy|March 22, 2008
Heat shock protein inhibitors increase the efficacy of measles virotherapyC Liu, C Erlichman, C J McDonald, et al.
Journal of the National Cancer Institute|August 21, 1991
Superiority of granisetron to dexamethasone plus prochlorperazine in the prevention of chemotherapy-induced emesisD Warr, A Willan, S Fine, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 1988
A randomized trial of two dose levels of cyclophosphamide, methotrexate, and fluorouracil chemotherapy for patients with metastatic breast cancerI F Tannock, N F Boyd, G DeBoer, et al.
Pageof 10

Showing results (61-70 of 95) with videos related to

Sort By:
Pageof 10
Cancer Research|December 1, 1991
Phase I pharmacokinetic and pharmacodynamic study of a new anthrapyrazole, CI-937 (DUP937)C Erlichman, M Moore, I G Kerr, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1994
Variability in the pharmacokinetics of cyclophosphamide, methotrexate and 5-fluorouracil in women receiving adjuvant treatment for breast cancerM J Moore, C Erlichman, J J Thiessen, et al.
Cancer Chemotherapy and Pharmacology|April 9, 2013
Open-label, dose-escalation, safety, pharmacokinetic, and pharmacodynamic study of intravenously administered CNF1010 (17-(allylamino)-17-demethoxygeldanamycin [17-AAG]) in patients with solid tumorsM W Saif, C Erlichman, T Dragovich, et al.
Arzneimittel-Forschung|June 1, 1988
Disposition of cyclophosphamide on two consecutive cycles of treatment in patients with ovarian carcinomaC Erlichman, S J Soldin, R W Hardy, et al.
Cancer|November 7, 1998
Molecular markers in male breast carcinomaD Rayson, C Erlichman, V J Suman, et al.
Cancer Treatment Reports|March 1, 1982
Combined radical radiation therapy and chemotherapy for primary squamous cell carcinoma of the anal canalB J Cummings, W D Rider, A R Harwood, et al.
American Journal of Clinical Oncology|February 1, 1996
A phase II trial of 5-fluorouracil and 1-leucovorin in patients with metastatic colorectal cancerC Erlichman, S Fine, I Kerr, et al.
Gene Therapy|March 22, 2008
Heat shock protein inhibitors increase the efficacy of measles virotherapyC Liu, C Erlichman, C J McDonald, et al.
Journal of the National Cancer Institute|August 21, 1991
Superiority of granisetron to dexamethasone plus prochlorperazine in the prevention of chemotherapy-induced emesisD Warr, A Willan, S Fine, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 1988
A randomized trial of two dose levels of cyclophosphamide, methotrexate, and fluorouracil chemotherapy for patients with metastatic breast cancerI F Tannock, N F Boyd, G DeBoer, et al.
Pageof 10